# Episode 492: Novel Biomarkers and Targets in Germ Cell Tumors

Page: https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors
Text version: https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors.md
Podcast: [The Uromigos](https://stenobird.com/podcast/the-uromigos-1214845)
Published: 2026-04-06T10:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-492-Novel-Biomarkers-and-Targets-in-Germ-Cell-Tumors-e3hb05a
Audio file: https://anchor.fm/s/13347ea8/podcast/play/117849706/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-2%2F421267842-44100-2-8dc0ebe46d00f.m4a
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors
Duration seconds: 2005

## Resource

This podcast features Dr. Mike Glover from MDACC discussing recent advances in germ cell tumor research, focusing on novel biomarkers like microRNA and ctDNA, and emerging therapies targeting Claudin-6. The conversation explores how these innovations could transform diagnosis, prognosis, and treatment strategies.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-uromigos-1214845/episode-492-novel-biomarkers-and-targets-in-germ-cell-tumors.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.